Superstring Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $114 Billion distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Zai Lab LTD with a value of $15.1B, Cytokinetics Inc with a value of $11.4B, Terns Pharmaceuticals, Inc. with a value of $11.2B, Structure Therapeutics Inc with a value of $9.97B, and Oric Pharmaceuticals, Inc. with a value of $9.73B.

Examining the 13F form we can see an increase of $34.9B in the current position value, from $79.3B to 114B.

Superstring Capital Management LP is based out at New York, NY

Below you can find more details about Superstring Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $114 Billion
Healthcare: $91.9 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $114 Billion
  • Prior Value $79.3 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 8 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.